Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in Myelofibrosis With Myeloid Metaplasia
NCT00245128Phase 2Terminated
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Aug 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in myelofibrosis with myeloid metaplasia (MMM), sponsored by OHSU Knight Cancer Institute. Started Aug 2005; status: terminated.
02
Drugs
03
Conditions
myelofibrosis with myeloid metaplasia (MMM)
Beyond the preview
Go deeper on NCT00245128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245128.